Last checked at Sareum Loss Narrows; Could Secure GBP900,000 From China License Deal
Sareum Loss Narrows; Could Secure GBP900,000 From China License Deal
26 Mar 20 11:46
- Home
- Share Prices
- NEX Exchange Share Prices
- Share Chat
- FX
- News
- Blogs
- RNS
- Media
- Trading
- Finance Tools
- Members
Latest Share Chat
Sareum Share News (SAR)
SAR Share
Price
SAR Share
News
SAR Share
Chat34
SAR Share
Trades32
SAR
Live RNS
SAR Share
Charts
SAR Level 2
Console
SAR Live
Share Price
SAR Broker
Ratings
SAR Directors
Deals
SAR Financial
Diary
SAR
Fundamentals
SAR Short
Positions
SAR
Media
SAR Information
Share Price Information for Sareum (SAR)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
0.38
Bid:
0.36
Ask:
0.40
Change:
-0.03
(-7.32%)
Spread:
0.04 (11.11%)
Open:
0.41
High:
0.415
Low:
0.375
Yest. Close:
0.41
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.26 Mar 20 11:46Sareum Holdings Happy With Progress Despite Mixed Year
Sareum Holdings Happy With Progress Despite Mixed Year
17 Dec 19 13:20Sareum Expects Possible Significant Delay To Sierra Milestone Payments
Sareum Expects Possible Significant Delay To Sierra Milestone Payments
17 Dec 19 11:55UK Shareholder Meetings Calendar - Next 7 Days
UK Shareholder Meetings Calendar - Next 7 Days
10 Dec 19 15:57Sareum Narrows Annual Loss As Immunotherapy Programmes Progress
Sareum Narrows Annual Loss As Immunotherapy Programmes Progress
15 Oct 19 11:43Sareum's SAR-20351 Inhibitor Reduces Tumour Growth In Various Cancers
Sareum's SAR-20351 Inhibitor Reduces Tumour Growth In Various Cancers
27 Sep 19 09:20Sareum Holdings upbeat ahead of cancer research presentation
(Sharecast News) - Specialist small molecule drug development company Sareum Holdings announced on Friday that it will present new preclinical data from its 'SDC-1802 TYK2/JAK1' inhibitor cancer research programme at the American Association for Cancer Research (AACR) National Cancer Institute (NCI) European Organisation for Research and Treatment of Cancer (EORTC) international conference, in late October in Boston, Massachusetts.
27 Sep 19 09:10Sareum Optimistic On Cancer Treatment As Partner Changes Focus
(Alliance News) - Small molecule drug developer Sareum Holdings PLC on Tuesday said investee Sierra Oncology will need to look at new options to progress development of a key drug.Sierra to
27 Aug 19 13:24Sareum Holdings expects broadly flat interim losses
(Sharecast News) - Drug developer Sareum expects interim losses to be broadly flat year-on-year as it continues to focus on the development of multiple treatments for cancer and autoimmune diseases.
27 Aug 19 08:35Sareum Raises GBP513,000 Through Discounted Placing For Pipeline Push
(Alliance News) - Sareum Holdings PLC said Tuesday it raised GBP513,000 through a discounted share placing by Hybridan LLP, whilst also opening the offer to retail investors through drug firm at ,
25 Jun 19 18:33Sareum Plans To Start Human Trials Of Two Drug Candidates In 2020
(Alliance News) - Sareum Holdings PLC on Thursday said it has been focusing on toxicology studies in its development of drug candidates SDC-1801 and SDC-1802 with a view to CONDUCT human trials in
13 Jun 19 15:49Sareum Notes Sierra Oncology's Positive Preliminary Results Of SRA737
LONDON (Alliance News) - Sareum Holdings PLC on Monday said it noted its licensee Sierra Oncology's webcast discussing clinical findings and possible next steps for SRA737, its oral checkpoint
3 Jun 19 17:38Sareum Reports Positive Data From Trials Of SRA737 In Advanced Cancer
LONDON (Alliance News) - Sareum Holdings PLC on Monday said that Sierra Oncology reported positive preliminary clinical data from two in-human studies of SRA737.Shares in the drug company a
3 Jun 19 10:02Sareum Interim Loss Deepens On Costs As Pipeline Continues Progress
LONDON (Alliance News) - Cancer drug discovery firm Sareum Holdings PLC said Monday its interim loss widened as costs rose, but it made progress with its key developmental programmes.For to
4 Mar 19 10:58Sareum's loss widens as development costs expand
(Sharecast News) - Sareum Holdings' shares dropped on Monday after the company reported a widened interim loss due to rising costs, though it stated progress had been made with key development programmes.
4 Mar 19 08:26